Preliminary Q2 2022 MDxHealth SA Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the MDxHealth August 2, 2022, business update. As a reminder, this conference call is being recorded.
Before we begin, I'd like to remind everyone that the company will make forward-looking statements during today's call, whether in the prepared remarks or during the Q&A session. These forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the Risk Factors section of the company's filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20-F filed with the SEC on April 25, 2022, and in subsequent filings.
At this time, I'd like to turn the conference over to Mr. Michael McGarrity, Chief Executive Officer of MDxHealth. Please go ahead, sir.
Thanks, Sarah. And thank you all for joining us for an exciting update for MDxHealth. With me today is Ron Kalfus, Chief Financial Officer.
As we announced today in our press
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |